Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Y **ong, C **ao, Z Li, X Yang - Chemical Society Reviews, 2021 - pubs.rsc.org
Glutathione (GSH), the main redox buffer, has long been recognized as a pivotal modulator
of tumor initiation, progression and metastasis. It is also implicated in the resistance of …
of tumor initiation, progression and metastasis. It is also implicated in the resistance of …
Recent progress of supramolecular chemotherapy based on host–guest interactions
M Yan, S Wu, Y Wang, M Liang, M Wang… - Advanced …, 2024 - Wiley Online Library
Chemotherapy is widely recognized as an effective approach for treating cancer due to its
ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional …
ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional …
Nanotechnology for COVID-19: therapeutics and vaccine research
The current global health threat by the novel coronavirus disease 2019 (COVID-19) requires
an urgent deployment of advanced therapeutic options available. The role of …
an urgent deployment of advanced therapeutic options available. The role of …
Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy
Prodrugs are chemically modified drug molecules that are inactive before administration.
After administration, they are converted in situ to parent drugs and induce the mechanism of …
After administration, they are converted in situ to parent drugs and induce the mechanism of …
[HTML][HTML] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
C Duan, M Yu, J Xu, BY Li, Y Zhao… - Biomedicine & …, 2023 - Elsevier
Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
Applications and challenges of ultra-small particle size nanoparticles in tumor therapy
J Xu, M Song, Z Fang, L Zheng, X Huang… - Journal of Controlled …, 2023 - Elsevier
With the development of nanotechnology, nanomedicines are widely used in tumor therapy.
However, biological barriers in the delivery of nanoparticles still limit their application in …
However, biological barriers in the delivery of nanoparticles still limit their application in …
Small‐molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery
G Li, B Sun, Y Li, C Luo, Z He, J Sun - Small, 2021 - Wiley Online Library
The antitumor efficiency and clinical translation of traditional nanomedicines is mainly
restricted by low drug loading, complex preparation technology, and potential toxicity …
restricted by low drug loading, complex preparation technology, and potential toxicity …
Antimicrobial hybrid amphiphile via dynamic covalent bonds enables bacterial biofilm dispersal and bacteria eradication
To tackle the problems caused by bacterial biofilms, herein, this study reports an
antimicrobial hybrid amphiphile (aHA) via dynamic covalent bonds for eradicating …
antimicrobial hybrid amphiphile (aHA) via dynamic covalent bonds for eradicating …
Development of high‐drug‐loading nanoparticles
Formulating drugs into nanoparticles offers many attractive advantages over free drugs
including improved bioavailability, minimized toxic side effects, enhanced drug delivery …
including improved bioavailability, minimized toxic side effects, enhanced drug delivery …
Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy
Nanocarrier-based drug delivery systems hold impressive promise for biomedical
application because of their excellent water dispersibility, prolonged blood circulation time …
application because of their excellent water dispersibility, prolonged blood circulation time …